(GLE) Societe Generale S.A. - Overview
Exchange: PA •
Country: France •
Currency: EUR •
Type: Common Stock •
ISIN: FR0000130809
Stock: Banking, Investment, Leasing, Insurance, Finance
Total Rating 50
Risk 24
Buy Signal -0.35
| Risk 5d forecast | |
|---|---|
| Volatility | 41.8% |
| Relative Tail Risk | -6.41% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.69 |
| Alpha | 63.90 |
| Character TTM | |
|---|---|
| Beta | 0.488 |
| Beta Downside | 1.509 |
| Drawdowns 3y | |
|---|---|
| Max DD | 26.60% |
| CAGR/Max DD | 2.18 |
EPS (Earnings per Share)
Revenue
Description: GLE Societe Generale S.A. March 05, 2026
Societe Generale S.A. (GLE) is a French financial services company. It provides banking, insurance, and investment solutions to a diverse client base including individuals, corporations, and institutions.
GLE operates through three primary segments: French Retail, Private Banking and Insurance; International Retail, Mobility and Leasing Services; and Global Banking and Investor Solutions. This structure allows the company to offer a broad range of services, from consumer credit and vehicle leasing to corporate finance and asset management. The banking sector is characterized by intense competition and evolving regulatory landscapes.
The company, founded in 1864, is headquartered in Paris, France, and is classified under the Regional Banks GICS sub-industry. Understanding the competitive landscape and regulatory environment for regional banks is crucial for a comprehensive analysis. For further data-driven insights into GLEs performance, consider exploring ValueRay.
Piotroski VR‑10 (Strict, 0-10) 4.0
| Net Income: 6.71b TTM > 0 and > 6% of Revenue |
| FCF/TA: -0.02 > 0.02 and ΔFCF/TA -1.09 > 1.0 |
| NWC/Revenue: -877.6% < 20% (prev -1759 %; Δ 881.8% < -1%) |
| CFO/TA -0.02 > 3% & CFO -26.43b > Net Income 6.71b |
| Net Debt (-28.06b) to EBITDA (7.36b): -3.81 < 3 |
| Current Ratio: 0.51 > 1.5 & < 3 |
| Outstanding Shares: last quarter (776.3m) vs 12m ago -2.54% < -2% |
| Gross Margin: 19.05% > 18% (prev -0.17%; Δ 1921 % > 0.5%) |
| Asset Turnover: 2.65% > 50% (prev 1.56%; Δ 1.10% > 0%) |
| Interest Coverage Ratio: -0.04 > 6 (EBITDA TTM 7.36b / Interest Expense TTM 33.56b) |
Altman Z'' -1.43
| A: -0.24 (Total Current Assets 372.42b - Total Current Liabilities 736.22b) / Total Assets 1546.64b |
| B: 0.03 (Retained Earnings 41.86b / Total Assets 1546.64b) |
| C: -0.00 (EBIT TTM -1.31b / Avg Total Assets 1563.11b) |
| D: 0.03 (Book Value of Equity 42.10b / Total Liabilities 1467.11b) |
| Altman-Z'' Score: -1.43 = CCC |
Beneish M -3.37
| DSRI: 0.06 (Receivables 1.39b/13.89b, Revenue 41.46b/24.57b) |
| GMI: 1.00 (fallback, negative margins) |
| AQI: 0.86 (AQ_t 0.72 / AQ_t-1 0.84) |
| SGI: 1.69 (Revenue 41.46b / 24.57b) |
| TATA: 0.02 (NI 6.71b - CFO -26.43b) / TA 1546.64b) |
| Beneish M-Score: -3.37 (Cap -4..+1) = AA |
What is the price of GLE shares?
As of March 07, 2026, the stock is trading at EUR 66.52 with a total of 3,834,688 shares traded.
Over the past week, the price has changed by -9.94%, over one month by -8.35%, over three months by +6.23% and over the past year by +63.85%.
Over the past week, the price has changed by -9.94%, over one month by -8.35%, over three months by +6.23% and over the past year by +63.85%.
Is GLE a buy, sell or hold?
Societe Generale S.A. has no consensus analysts rating.
What are the forecasts/targets for the GLE price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 79.6 | 19.7% |
| Analysts Target Price | - | - |
GLE Fundamental Data Overview March 06, 2026
Market Cap USD = 61.46b (52.84b EUR * 1.1632 EUR.USD)
P/E Trailing = 10.35
P/E Forward = 8.8889
P/S = 2.0499
P/B = 0.7255
P/EG = 1.8913
Revenue TTM = 41.46b EUR
EBIT TTM = -1.31b EUR
EBITDA TTM = 7.36b EUR
Long Term Debt = unknown (none)
Short Term Debt = 20.41b EUR (from shortTermDebt, two quarters ago)
Debt = 167.07b EUR (from shortLongTermDebtTotal, last quarter)
Net Debt = -28.06b EUR (from netDebt column, last quarter)
Enterprise Value = -149.26b EUR (52.84b + Debt 167.07b - CCE 369.17b)
Interest Coverage Ratio = -0.04 (Ebit TTM -1.31b / Interest Expense TTM 33.56b)
EV/FCF = 4.77x (Enterprise Value -149.26b / FCF TTM -31.27b)
FCF Yield = 20.95% (FCF TTM -31.27b / Enterprise Value -149.26b)
FCF Margin = -75.44% (FCF TTM -31.27b / Revenue TTM 41.46b)
Net Margin = 16.18% (Net Income TTM 6.71b / Revenue TTM 41.46b)
Gross Margin = 19.05% ((Revenue TTM 41.46b - Cost of Revenue TTM 33.56b) / Revenue TTM)
Gross Margin QoQ = none% (prev none%)
Tobins Q-Ratio = -0.10 (set to none) (Enterprise Value -149.26b / Total Assets 1546.64b)
Interest Expense / Debt = 20.09% (Interest Expense 33.56b / Debt 167.07b)
Taxrate = 18.79% (804.0m / 4.28b)
NOPAT = -1.06b (EBIT -1.31b * (1 - 18.79%)) [loss with tax shield]
Current Ratio = 0.51 (Total Current Assets 372.42b / Total Current Liabilities 736.22b)
Debt / Equity = 2.38 (Debt 167.07b / totalStockholderEquity, last quarter 70.14b)
Debt / EBITDA = -3.81 (Net Debt -28.06b / EBITDA 7.36b)
Debt / FCF = 0.90 (negative FCF - burning cash) (Net Debt -28.06b / FCF TTM -31.27b)
Total Stockholder Equity = 69.81b (last 4 quarters mean from totalStockholderEquity)
RoA = 0.43% (Net Income 6.71b / Total Assets 1546.64b)
RoE = 9.61% (Net Income TTM 6.71b / Total Stockholder Equity 69.81b)
RoCE = -0.16% (EBIT -1.31b / Capital Employed (Total Assets 1546.64b - Current Liab 736.22b))
RoIC = -0.44% (negative operating profit) (NOPAT -1.06b / Invested Capital 241.28b)
WACC = 14.25% (E(52.84b)/V(219.91b) * Re(7.71%) + D(167.07b)/V(219.91b) * Rd(20.09%) * (1-Tc(0.19)))
Discount Rate = 7.71% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -33.33 | Cagr: -1.16%
[DCF] Fair Price = unknown (Cash Flow -31.27b)
EPS Correlation: 12.48 | EPS CAGR: 13.54% | SUE: 1.51 | # QB: 3
Revenue Correlation: 30.62 | Revenue CAGR: 34.91% | SUE: 4.0 | # QB: 1
EPS next Quarter (2026-06-30): EPS=2.00 | Chg7d=+0.000 | Chg30d=+0.010 | Revisions Net=+2 | Analysts=2
EPS current Year (2026-12-31): EPS=7.65 | Chg7d=+0.000 | Chg30d=+0.368 | Revisions Net=+7 | Growth EPS=+12.6% | Growth Revenue=+2.7%
EPS next Year (2027-12-31): EPS=8.85 | Chg7d=+0.000 | Chg30d=+0.454 | Revisions Net=+9 | Growth EPS=+15.7% | Growth Revenue=+3.7%
[Analyst] Revisions Ratio: +1.00 (2 Up / 0 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = -1.7% (Discount Rate 7.9% - Earnings Yield 9.7%)
[Growth] Growth Spread = +5.3% (Analyst 3.6% - Implied -1.7%)
P/E Trailing = 10.35
P/E Forward = 8.8889
P/S = 2.0499
P/B = 0.7255
P/EG = 1.8913
Revenue TTM = 41.46b EUR
EBIT TTM = -1.31b EUR
EBITDA TTM = 7.36b EUR
Long Term Debt = unknown (none)
Short Term Debt = 20.41b EUR (from shortTermDebt, two quarters ago)
Debt = 167.07b EUR (from shortLongTermDebtTotal, last quarter)
Net Debt = -28.06b EUR (from netDebt column, last quarter)
Enterprise Value = -149.26b EUR (52.84b + Debt 167.07b - CCE 369.17b)
Interest Coverage Ratio = -0.04 (Ebit TTM -1.31b / Interest Expense TTM 33.56b)
EV/FCF = 4.77x (Enterprise Value -149.26b / FCF TTM -31.27b)
FCF Yield = 20.95% (FCF TTM -31.27b / Enterprise Value -149.26b)
FCF Margin = -75.44% (FCF TTM -31.27b / Revenue TTM 41.46b)
Net Margin = 16.18% (Net Income TTM 6.71b / Revenue TTM 41.46b)
Gross Margin = 19.05% ((Revenue TTM 41.46b - Cost of Revenue TTM 33.56b) / Revenue TTM)
Gross Margin QoQ = none% (prev none%)
Tobins Q-Ratio = -0.10 (set to none) (Enterprise Value -149.26b / Total Assets 1546.64b)
Interest Expense / Debt = 20.09% (Interest Expense 33.56b / Debt 167.07b)
Taxrate = 18.79% (804.0m / 4.28b)
NOPAT = -1.06b (EBIT -1.31b * (1 - 18.79%)) [loss with tax shield]
Current Ratio = 0.51 (Total Current Assets 372.42b / Total Current Liabilities 736.22b)
Debt / Equity = 2.38 (Debt 167.07b / totalStockholderEquity, last quarter 70.14b)
Debt / EBITDA = -3.81 (Net Debt -28.06b / EBITDA 7.36b)
Debt / FCF = 0.90 (negative FCF - burning cash) (Net Debt -28.06b / FCF TTM -31.27b)
Total Stockholder Equity = 69.81b (last 4 quarters mean from totalStockholderEquity)
RoA = 0.43% (Net Income 6.71b / Total Assets 1546.64b)
RoE = 9.61% (Net Income TTM 6.71b / Total Stockholder Equity 69.81b)
RoCE = -0.16% (EBIT -1.31b / Capital Employed (Total Assets 1546.64b - Current Liab 736.22b))
RoIC = -0.44% (negative operating profit) (NOPAT -1.06b / Invested Capital 241.28b)
WACC = 14.25% (E(52.84b)/V(219.91b) * Re(7.71%) + D(167.07b)/V(219.91b) * Rd(20.09%) * (1-Tc(0.19)))
Discount Rate = 7.71% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -33.33 | Cagr: -1.16%
[DCF] Fair Price = unknown (Cash Flow -31.27b)
EPS Correlation: 12.48 | EPS CAGR: 13.54% | SUE: 1.51 | # QB: 3
Revenue Correlation: 30.62 | Revenue CAGR: 34.91% | SUE: 4.0 | # QB: 1
EPS next Quarter (2026-06-30): EPS=2.00 | Chg7d=+0.000 | Chg30d=+0.010 | Revisions Net=+2 | Analysts=2
EPS current Year (2026-12-31): EPS=7.65 | Chg7d=+0.000 | Chg30d=+0.368 | Revisions Net=+7 | Growth EPS=+12.6% | Growth Revenue=+2.7%
EPS next Year (2027-12-31): EPS=8.85 | Chg7d=+0.000 | Chg30d=+0.454 | Revisions Net=+9 | Growth EPS=+15.7% | Growth Revenue=+3.7%
[Analyst] Revisions Ratio: +1.00 (2 Up / 0 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = -1.7% (Discount Rate 7.9% - Earnings Yield 9.7%)
[Growth] Growth Spread = +5.3% (Analyst 3.6% - Implied -1.7%)